Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Breast Cancer Res Treat. 2009 Apr 30;119(2):453–462. doi: 10.1007/s10549-009-0404-3

Table 1.

Multivariate analysis of polymorphic variants of the mitotic kinase genes with Ptrend ≤ 0.05

Gene Name rsID Major Allele Homozygotes
Heterozygotes
Minor Allele Homozygotes
OR (95%CI)
Per Allele
Ptrend Q value
Cases Controls Cases Controls Cases Controls
BRD4 rs4808278 613 676 166 157 18 10 1.27 (1.02-1.58) 0.03 0.77
BUB1B rs7182070 602 590 180 234 16 19 0.81 (0.66-1.00) 0.05 0.77
CDC42BPA rs2802269 659 666 134 168 5 9 0.77 (0.61-0.98) 0.04 0.77
CDC42BPA rs1929860 345 403 358 353 95 87 1.17 (1.00-1.36) 0.05 0.77
CIT rs17496224 694 770 102 72 1 1 1.49 (1.08-2.05) 0.02 0.77
DBF4 rs9655955 706 718 89 119 3 6 0.73 (0.55-0.97) 0.03 0.77
EIF2AK4 rs2291627 646 715 143 124 9 4 1.34 (1.04-1.73) 0.02 0.77
FYN rs6914091 221 297 412 414 165 131 1.33 (1.14-1.54) 0.0002 0.06
FYN rs1465061 290 360 377 388 129 92 1.32 (1.13-1.53) 0.0003 0.06
FYN rs12910 182 247 416 421 200 175 1.27 (1.10-1.46) 0.001 0.19
KIAA0999 rs10047459 544 612 227 208 27 23 1.22 (1.01-1.48) 0.04 0.77
KIAA0999 rs1473177 644 647 147 185 7 11 0.79 (0.63-0.99) 0.04 0.77
KIAA0999 rs17120241 625 614 156 213 17 15 0.81 (0.65-0.99) 0.04 0.77
PAK6 rs4924445 263 328 390 386 145 129 1.17 (1.01-1.35) 0.03 0.77
PAK6 rs7169803 471 451 284 335 43 57 0.84 (0.71-0.99) 0.04 0.77
PRKACB rs12728744 734 750 63 89 1 3 0.70 (0.50-0.98) 0.04 0.77
ROCK1 rs17202375 638 714 153 124 7 5 1.43 (1.11-1.84) 0.005 0.53
RYK rs10935104 568 639 204 190 26 14 1.29 (1.05-1.58) 0.01 0.77
RYK rs9283588 595 661 182 174 21 8 1.30 (1.05-1.61) 0.02 0.77
RYK rs1131262 595 661 182 173 21 9 1.28 (1.04-1.59) 0.02 0.77
STK4 rs17420378 420 393 313 362 64 86 0.85 (0.73-0.99) 0.04 0.77
STK4 rs6073636 420 394 313 364 64 85 0.85 (0.73-1.00) 0.05 0.77

NOTE: rsID: SNP identification number; OR: odds ratio; CI: confidence interval

Logistic regression analysis adjusted for age, geographical region, menopausal status, age at menarche, oral contraceptive use, age first birth, hormone replacement therapy and pack-years cigarette smoking